Author: Milena Atanasova

checklist top mdr questions

[Whitepaper] Checklist – Top MDR questions

In 2017 the Medical Devices Regulation (MDR) was published and marked the start of a four-year journey of transition from MDD to AIMDD. From the 26th of May 2021, the MDR will be fully applicable. During the transition, the manufacturers should have informed themselves and...

Read More
explanation what stands for l1-l5 serialization solution provider

[Blog] What stands for the L1-L5 serialization solution provider?

Updated: 5th March 2021   L1 -L5 serialization solution - what actually is included in the end-to-end track and trace solution?   In fact, this is jargon from the highly technical field of supply chain management. Here is the simplest explanation with less jargon. Moreover, what makes SoftGroup the...

Read More
pharma aggregation

[Blog] Why Aggregation in Pharma Industry is the Future of Traceability?

  Pharma Aggregation is a new opportunity in Supply Chain drug traceability.   It has been considered as the next logical step after serialization by the industry expert, especially when the single package serialization is identified as proofed protection against counterfeiting and drug integrity.   The USA’s Drug Supply Chain...

Read More

By continuing to use the site, you agree to the terms of our Privacy and Cookies Policy and the use of cookies. Privacy and Cookies Policy

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.